Eisai adopts Medidata’s AI-driven platform for clinical trials
Eisai has adopted Medidata's Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience. Launched …
Eisai has adopted Medidata's Clinical Data Studio, which aims to transform and modernising the clinical trial efficiency and patient experience. Launched …
Viridian Therapeutics has announced the completion of subject enrolment for its Phase III THRIVE-2 clinical trial of VRDN-001, aimed at …
Non-Hodgkin’s lymphoma (NHL) is a type of cancer that originates in the lymphatic system, part of the body's immune system. …
Ariceum Therapeutics has initiated a Phase I trial for iodine-123 labelled ¹²³I-ATT001 in brain cancer patients, as the company eyes …
The chronic obstructive pulmonary disorder (COPD) market has laid relatively dormant for the past few years until recently. Several biologics which …
Passage Bio has plans to talk with the US Food and Drug Administration (FDA) to initiate trials of its investigative …
Autobahn Therapeutics has secured $100 in an oversubscribed Series C financing round for the commencement of two Phase II clinical …
Imperative Care has announced positive data from a study of its Zoom reperfusion system, suggesting reduced rates of rescue therapy …
Inimmune has dosed the first subject in its Phase I clinical trial of INI-4001, an immunotherapeutic agent designed for treating …
European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve …
Sage Therapeutics and Biogen have disclosed topline results from the Phase II KINETIC 2 study, in which SAGE-324 (BIIB124) showed …
Pfizer has reported positive data from the Phase III AFFINE clinical trial of investigational gene therapy, giroctocogene fitelparvovec, to treat …
Spectral AI has added three clinical trials for a US pivotal study evaluating its AI-based diagnostics platform DeepView. The addition of …
Paratek Pharmaceuticals has announced positive topline efficacy and safety data from a global, Phase III, post-marketing commitment study of its …
NewAmsterdam Pharma has completed the enrolment of 407 patients in the pivotal Phase III TANDEM clinical trial evaluating obicetrapib in …